Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Sams-Dodd

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Drug Discovery Today|April 4, 2006
Strategies to optimize the validity of disease models in the drug discovery processFrank Sams-Dodd
Drug Discovery Today|February 19, 2005
Target-based drug discovery: is something wrong?Frank Sams-Dodd
Basic & Clinical Pharmacology & Toxicology|November 18, 2004
(+) MK-801 and phencyclidine induced neurotoxicity do not cause enduring behaviours resembling the positive and negative symptoms of schizophrenia in the ratFrank Sams-Dodd
Drug Discovery Today|August 2, 2005
Optimizing the discovery organization for innovationFrank Sams-Dodd
Drug Discovery Today|November 8, 2012
Is poor research the cause of the declining productivity of the pharmaceutical industry? An industry in need of a paradigm shiftFrank Sams-Dodd
Drug Discovery Today|April 26, 2006
Drug discovery: selecting the optimal approachFrank Sams-Dodd
Drug Discovery Today|March 31, 2007
Research & market strategy: how choice of drug discovery approach can affect market positionFrank Sams-Dodd
Wounds : a Compendium of Clinical Research and Practice|November 13, 2018
Time to Abandon Antimicrobial Approaches in Wound Healing: A Paradigm ShiftJeanette Sams-Dodd, Frank Sams-Dodd
Wounds : a Compendium of Clinical Research and Practice|April 27, 2020
Micropore Particle Technology Promotes Wound Healing, Whereas Polyhexamethylene Biguanide Causes Tissue Degeneration: A Case ReportJeanette Sams-Dodd, Frank Sams-Dodd
Frontiers in Public Health|July 30, 2025
The contribution of antimicrobials and antimicrobial resistance to climate change and a possible way to reverse it whilst still offering high quality healthcare-a conceptual analysisJeanette Sams-Dodd, Frank Sams-Dodd
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Drug Discovery Today|April 4, 2006
Strategies to optimize the validity of disease models in the drug discovery processFrank Sams-Dodd
Drug Discovery Today|February 19, 2005
Target-based drug discovery: is something wrong?Frank Sams-Dodd
Basic & Clinical Pharmacology & Toxicology|November 18, 2004
(+) MK-801 and phencyclidine induced neurotoxicity do not cause enduring behaviours resembling the positive and negative symptoms of schizophrenia in the ratFrank Sams-Dodd
Drug Discovery Today|August 2, 2005
Optimizing the discovery organization for innovationFrank Sams-Dodd
Drug Discovery Today|November 8, 2012
Is poor research the cause of the declining productivity of the pharmaceutical industry? An industry in need of a paradigm shiftFrank Sams-Dodd
Drug Discovery Today|April 26, 2006
Drug discovery: selecting the optimal approachFrank Sams-Dodd
Drug Discovery Today|March 31, 2007
Research & market strategy: how choice of drug discovery approach can affect market positionFrank Sams-Dodd
Wounds : a Compendium of Clinical Research and Practice|November 13, 2018
Time to Abandon Antimicrobial Approaches in Wound Healing: A Paradigm ShiftJeanette Sams-Dodd, Frank Sams-Dodd
Wounds : a Compendium of Clinical Research and Practice|April 27, 2020
Micropore Particle Technology Promotes Wound Healing, Whereas Polyhexamethylene Biguanide Causes Tissue Degeneration: A Case ReportJeanette Sams-Dodd, Frank Sams-Dodd
Frontiers in Public Health|July 30, 2025
The contribution of antimicrobials and antimicrobial resistance to climate change and a possible way to reverse it whilst still offering high quality healthcare-a conceptual analysisJeanette Sams-Dodd, Frank Sams-Dodd
Pageof 2